Literature DB >> 24634679

Letter to the editor.

Raymond Sw Tsang1, Frances B Jamieson2, Brigitte Lefebvre3, Rodica Gilca4.   

Abstract

Year:  2014        PMID： 24634679      PMCID： PMC3950991          DOI： 10.1155/2014/847192

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN： 1712-9532            Impact factor:   2.471


× No keyword cloud information.
  17 in total

1.  Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines.

Authors:  Shamez N Ladhani; Jessica S Flood; Mary E Ramsay; Helen Campbell; Stephen J Gray; Edward B Kaczmarski; Richard H Mallard; Malcolm Guiver; Lynne S Newbold; Ray Borrow
Journal:  Vaccine       Date:  2012-03-17       Impact factor: 3.641

2.  Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data.

Authors:  Ryan T Novak; Jean Ludovic Kambou; Fabien Vk Diomandé; Tiga F Tarbangdo; Rasmata Ouédraogo-Traoré; Lassana Sangaré; Clement Lingani; Stacey W Martin; Cynthia Hatcher; Leonard W Mayer; F Marc Laforce; Fenella Avokey; Mamoudou H Djingarey; Nancy E Messonnier; Sylvestre R Tiendrébéogo; Thomas A Clark
Journal:  Lancet Infect Dis       Date:  2012-07-18       Impact factor: 25.071

3.  Invasive meningococcal disease in Quebec, Canada, due to an emerging clone of ST-269 serogroup B meningococci with serotype antigen 17 and serosubtype antigen P1.19 (B:17:P1.19).

Authors:  Dennis K S Law; Manon Lorange; Louise Ringuette; Réjean Dion; Michel Giguère; Averil M Henderson; Jan Stoltz; Wendell D Zollinger; Philippe De Wals; Raymond S W Tsang
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

4.  Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis.

Authors:  J Finne; M Leinonen; P H Mäkelä
Journal:  Lancet       Date:  1983-08-13       Impact factor: 79.321

5.  Invasive serogroup B Neisseria meningitidis in Quebec, Canada, 2003 to 2010: persistence of the ST-269 clone since it first emerged in 2003.

Authors:  Jianwei Zhou; Brigitte Lefebvre; Saul Deng; Rodica Gilca; Genevieve Deceuninck; Dennis K S Law; Philippe De Wals; Raymond S W Tsang
Journal:  J Clin Microbiol       Date:  2012-02-15       Impact factor: 5.948

6.  Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction.

Authors:  Caroline L Trotter; Nick J Andrews; Edward B Kaczmarski; Elizabeth Miller; Mary E Ramsay
Journal:  Lancet       Date:  2004 Jul 24-30       Impact factor: 79.321

7.  Prolonged university outbreak of meningococcal disease associated with a serogroup B strain rarely seen in the United States.

Authors:  Sema Mandal; Henry M Wu; Jessica R MacNeil; Kimberly Machesky; Jocelyn Garcia; Brian D Plikaytis; Kim Quinn; Larry King; Susanna E Schmink; Xin Wang; Leonard W Mayer; Thomas A Clark; James R Gaskell; Nancy E Messonnier; Mary DiOrio; Amanda C Cohn
Journal:  Clin Infect Dis       Date:  2013-04-17       Impact factor: 9.079

Review 8.  Genetics and evolution of Neisseria meningitidis: importance for the epidemiology of meningococcal disease.

Authors:  Dominique A Caugant
Journal:  Infect Genet Evol       Date:  2008-04-10       Impact factor: 3.342

Review 9.  Population genetics and molecular epidemiology of Neisseria meningitidis.

Authors:  D A Caugant
Journal:  APMIS       Date:  1998-05       Impact factor: 3.205

Review 10.  Meningococcal carriage and disease--population biology and evolution.

Authors:  Dominique A Caugant; Martin C J Maiden
Journal:  Vaccine       Date:  2009-05-21       Impact factor: 3.641
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.